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Abstract
Background: Insulin stimulates glucose uptake by adipocytes through increasing translocation of
the glucose transporter GLUT4 from an intracellular compartment to the plasma membrane.
Fusion of GLUT4-containing vesicles at the cell surface is thought to involve phospholipase D
activity, generating the signalling lipid phosphatidic acid, although the mechanism of action is not yet
clear.
Results: Here we report the identification of a putative phosphatidic acid-binding motif in a
GLUT4 intracellular loop. Mutation of this motif causes a decrease in the insulin-induced exposure
of GLUT4 at the cell surface of 3T3-L1 adipocytes via an effect on vesicle fusion.
Conclusion: The potential phosphatidic acid-binding motif identified in this study is unique to
GLUT4 among the sugar transporters, therefore this motif may provide a unique mechanism for
regulating insulin-induced translocation by phospholipase D signalling.
Background
The lipid second messenger, phosphatidic acid (PtdOH)
is produced by phospholipase D (PLD) in a variety of
intracellular signalling pathways, including cell adhesion
and migration, vesicular trafficking and phagocytosis [1-
3]. Phosphatidic acid transduces the signal by altering the
localisation and/or activity of its target proteins. A
number of proteins are known to be regulated by PtdOH
in this way, such as the cyclic AMP phosphodiesterase
PDE4A1 [4], Raf-1 kinase [5], sphingosine-1-kinase [6],
phospholipase C isoforms [7], atypical protein kinase C
isoforms [8], and p47-phox [9].
Identification of PtdOH-target proteins is often achieved
by dissection of the pathways involving PLD, however,
screening methods using a PtdOH-coated resin have indi-
cated a number of interesting potential target proteins
such as N-ethylmaleimide-sensitive factor (NSF),
coatomer and ARF proteins [10]. Phage display is a well-
established method for identifying novel proteins capable
of interactions with a range of ligands, including proteins
[11,12], lipids [13] and carbohydrates [14], so was used in
the present study to identify potential PtdOH-target pro-
teins. This highlighted a potential PtdOH-binding motif
in the transmembrane solute transporter GLUT4.
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number of lipid signalling molecules, including
PtdIns(3,4,5)P3, PtdIns(3)P, and PtdIns(4,5)P2. These lip-
ids play a major role in insulin signalling, as numerous
studies have shown the PI3K inhibitor wortmannin to
block insulin-stimulated increases in GLUT4 transloca-
tion and glucose uptake by over 90% [15-17]. The role of
PLD-generated PtdOH in stimulation of glucose uptake is
gradually being accepted. Some studies have demon-
strated inhibition of GLUT4 translocation or glucose
uptake with the inhibitor of PLD signalling, primary buta-
nol [18,19], whereas another reported no such effect [20].
The work by Millar et al used a lower concentration of
butanol and higher concentration of insulin than the
other studies, thus it is possible that the stimulus was too
great for the lower level of inhibitor to show an effect.
Insulin appears capable of stimulating PLD activity [21-
23], although the issue is complicated by the suggestion
that the alcohol used to measure PLD activity may inhibit
the insulin receptor [24]. PLD can be activated by ARF
family proteins [25] and brefeldin A, which can inhibit
the GTP loading of certain ARF proteins, inhibits insulin
stimulation of PLD [21]. Increasing cellular levels of PLD
protein by microinjection or viral transfection potentiates
GLUT4 translocation in response to insulin [23,26].
Decreasing PLD1 levels with siRNA reduces GLUT4 expo-
sure at the cell surface by affecting fusion, but not translo-
cation or docking of the GLUT4-containing vesicles.
Together these studies suggest an ill-defined role for PLD
in the fusion of GLUT4-containing vesicles at the plasma
membrane.
The phage display technique used in this study identified
a motif present in GLUT4, but absent in other GLUT fam-
ily members that are not thought to be regulated by PLD.
Thus the potential PtdOH-binding motif was investigated
for its involvement in insulin-stimulated GLUT4 translo-
cation. We present here results showing that mutation of
this motif impairs exposure of GLUT4 at the surface of
3T3-L1 adipocytes, via an effect on fusion of GLUT4-con-
taining vesicles with the plasma membrane.
Results
Screening by phage display
Potential phosphatidic acid (PtdOH)-binding motifs were
identified by phage display using a randomised 12-mer
phage library. Phage were panned over plastic and phos-
phatidylcholine-coated surfaces to remove non-specific
hydrophobic surface-binding phage before incubation on
the PtdOH-coated surface. Phage bound to the PtdOH
surface were eluted with glycerol-3-phosphate which
resembles the PtdOH headgroup to increase specificity of
selection. Sequencing the resulting PtdOH-selected phage
demonstrated a variety of 12-mer peptides consisting of
predominantly hydrophobic and basic residues, in agree-
ment with the characteristics of known PtdOH-binding
sites such as Raf-1 kinase and p47-phox. The peptides
were used as BLAST queries searching specifically for short
nearly exact matches; this analysis returned a number of
potential PtdOH-binding proteins. Notably, using the
two resulting phage sequences FLKSQWLDRMLG and
LLKSQWLDRMLG, the search identified the sequence
SQWL-R – ML present in the solute transporter GLUT4, a
sequence conserved in human, rat, mouse, pig and bovine
genes. This was chosen for further study as GLUT4 trans-
location in response to insulin is believed to involve phos-
pholipase D (PLD) signalling. The putative PtdOH-
binding motif, SQWL, is located in the first intracellular
loop of GLUT4, proximal to the third transmembrane
helix and suitably placed to mediate interactions with a
membrane lipid molecule. Notably, the other members of
this solute transporter family, which are not thought to be
regulated by PLD, do not contain this SQWL motif (Figure
1).
Mutation of the SQWL motif permits translocation of 
GLUT4
To allow assessment of GLUT4 translocation, GLUT4 con-
taining an HA-tag in the first exofacial loop was tagged
with GFP at the C-terminus. This allows cell surface-
exposed GLUT4 to be measured relative to the total level
of exogenous protein expressed, by comparing the ratio of
HA to GFP in non-permeabilised cells. Figure 2a demon-
strates that insulin stimulates the translocation of this
double-tagged GLUT4 to the plasma membrane in trans-
fected cells. 3T3-L1 adipocytes were also transfected with
a dual-tagged GLUT4 in which the putative PtdOH-bind-
ing motif, SQWL, had been mutated to alanine residues;
insulin was still able to stimulate translocation of this
transporter, as assessed by confocal microscopy (Figure
2b). Similar data was obtained using transfected L6 myob-
lasts (not shown).
Mutation of the SQWL motif reduces GLUT4 cell surface 
exposure in response to insulin
To quantify the degree of GLUT4 exposure at the cell sur-
face, we used the ratio of cell surface-exposed HA epitope
signal to whole cell GFP signal. This effectively normalises
the level of HA signal to the level of exogenous protein
expressed in the cell, and therefore allows comparison of
one cell with another. Quantification of the HA:GFP sig-
nal ratio from confocal microscope images of transfected
adipocytes showed that wild type GLUT4HA-GFP demon-
strated a five-fold increase in GLUT4 exposure at the cell
surface in response to insulin. In contrast the mutated
GLUT4 showed a decreased response to insulin, 20% ±
3% (mean ± SEM, ANOVA P < 0.0005) lower than for the
wild type protein (Figure 3).Page 2 of 8
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ysis, in which the ratio of HA:GFP within a region of inter-
est corresponding exclusively to the plasma membrane
was measured. This provides an indication of the effi-
ciency by which GLUT4 that has translocated to the
plasma membrane is inserted into the membrane leaflet
(i.e. fusion), and effectively normalises the HA signal to
the level of GLUT4HA-GFP that has translocated to the
membrane region to allow comparison between different
cells. Analysis of the 4A mutant GLUT4 cells (Figure 4)
showed that the mutation most likely affects fusion of
GLUT4-containing vesicles at the cell surface, since the
ratio of HA:GFP in the plasma membrane was lower than
for the wild type protein (78% ± 3.7% mean ± SEM, nor-
malised to wild type, t-test on means P < 0.05, ANOVA P
< 0.0005). In contrast, the mutation had no significant
effect on the insulin-stimulated translocation of GLUT4 to
the plasma membrane region, as indicated by the ratio of
plasma membrane GFP:whole cell GFP signal (1.21 ±
0.26 for wild type, mean ± SEM, 1.08 ± 0.28 for 4A
mutant).
Discussion
Insulin-induced glucose uptake via increased transloca-
tion of GLUT4 is believed to require PLD activity. Evi-
dence for the role of PLD in insulin signalling has come
from various methods, including treatment with the ARF
inhibitor brefeldin A [21], microinjection or viral transfec-
tion of PLD [23,26], and PLD siRNA [23]. The siRNA
study indicated a role for PLD specifically at the plasma
membrane, regulating fusion of the GLUT4-containing
vesicles at the cell surface.
There are several points at which PLD signalling could reg-
ulate GLUT4 cell surface expression. Firstly, PtdOH is a
fusogenic lipid, promoting increased membrane curva-
ture [27], so PtdOH generation may favour increased
membrane curvature to allow fusion of GLUT4 vesicles to
occur. Secondly, PtdOH may have a more defined role in
signalling to regulate GLUT4 vesicle fusion. For example,
fusion of GLUT4-containing vesicles with the plasma
membrane involves formation of a trans SNARE complex
between the v-SNARE VAMP2 and the t-SNAREs syntaxin-
4 and SNAP23. which is later recycled by the proposed
PtdOH-binding protein NSF. PLD-generated PtdOH
could stimulate the ATPase activity of NSF to increase
ClustalX alignment of glucose transporter family sequencesFigure 1
ClustalX alignment of glucose transporter family sequences. Amino acid sequences of the known glucose transporter 
family members were aligned using ClustalX. The potential PtdOH binding motif SQWLxRML (shown by boxed region) is only 
found in GLUT4, located in the cytoplasmic loop between helices two and three. Lower panel shows the alignment of the 
GLUT4 region with the phage display peptide, with homologous residues in bold type.Page 3 of 8
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vesicle fusion. PtdOH also stimulates phosphatidylinosi-
tol 4-phosphate 5-kinase and atypical protein kinase Cζ
activity, both enzymes involved in exocytosis [28-31]. As
Unc13, the C. Elegans homologue of munc13 involved in
exocytosis, binds diacylglycerol [32], increased phos-
phatidylinositol 4-phosphate 5-kinase activity could lead
to increased DAG formation by phospholipase C and
thereby regulate exocytosis via munc13. Additionally,
overexpression of PKCζ potentiates insulin-stimulated
GLUT4 translocation and glucose uptake via interaction
with munc18c [33]. Munc18c binds syntaxin-4, inhibiting
interactions between syntaxin-4 and VAMP2. This inhibi-
tion can be relieved by insulin-stimulated interaction of
PKCζ with munc18c, enabling fusion to occur. Thus
increased PtdOH levels could increase vesicle docking,
tethering and fusion by a range of mechanisms. Here we
have investigated a novel third hypothesis for regulation
of GLUT4 translocation by PLD-generated PtdOH, a direct
interaction of PtdOH with the GLUT4 protein.
Phage display, a well-established technique for identify-
ing novel protein-ligand interaction motifs [11-14], high-
lighted a potential PtdOH-binding motif in the GLUT4
first intracellular loop. Mutation of this sequence reduced
the insulin-induced exposure of GLUT4 at the cell surface
of 3T3-L1 adipocytes by affecting fusion of the GLUT4-
containing vesicles with the plasma membrane. It was not
possible to directly experimentally measure PtdOH bind-
ing by GLUT4 protein, so an interaction between PtdOH
and the SQWL motif in vivo cannot be definitively demon-
strated. Since GLUT4 is a transmembrane protein, any
additional specific protein-lipid interactions need not be
sufficiently high affinity to enable detection of such inter-
actions, as in vivo the proposed binding site would already
be in close proximity to the lipid.
Inhibition of PLD activity by siRNA has been shown to
reduce fusion of GLUT4 vesicles. This can be rescued by
addition of lyso-phosphatidylcholine, another fusogenic
lipid. Simply favouring membrane curvature by the addi-
tion of fusogenic lipids may be sufficient to overcome the
energy barrier associated with vesicle fusion in an experi-
Mutant GLUT4 shows less response to insulin than wild type GLUT4 in 3T3-L1 adipocytesFigure 3
Mutant GLUT4 shows less response to insulin than 
wild type GLUT4 in 3T3-L1 adipocytes. 3T3-L1 adi-
pocytes were transfected with wild type (WT, black bars) or 
4A mutant (MUT, grey bars) pGLUT4HA-GFP and serum-
starved for 4 hr, then stimulated with 83 nM insulin for 30 
min. GLUT4 translocation was measured by quantitative con-
focal microscopy as described in Materials and Methods. 
Data are means of 3 independent experiments ± SEM. A 
ratio of 1.0 was set for insulin-stimulated wild type cells to 
normalise the data between the experiments. * indicates val-
ues are significantly different (ANOVA P < 0.0005).
Dual-tagged wild type and mutant GLUT4 translocates to the plasma m mbrane in response to insulin s imulation in 3T3-L1 dipocytesFigure 2
Dual-tagged wild type and mutant GLUT4 translo-
cates to the plasma membrane in response to insulin 
stimulation in 3T3-L1 adipocytes. 3T3-L1 adipocytes 
were transiently transfected with (a) wild type or (b) 4A 
mutant GLUT4HA-GFP and serum starved for 4 hr, stimu-
lated with 83 nM insulin for 10 min then fixed for confocal 
microscopy as described in Materials and Methods. Green 
staining shows total GLUT4HA-GFP, red denotes surface 
exposed HA epitope.Page 4 of 8
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tion in vivo. The current work suggests that fusion of
GLUT4-contining vesicles with the plasma membrane is
facilitated by a change in GLUT4 conformation upon
binding to PtdOH, such that GLUT4 is better recognised
by other regulators of vesicle fusion and/or allowing
adoption of increased membrane curvature necessary for
the formation of the fusion pore intermediate. The con-
formation of membrane-associated proteins has previ-
ously been shown to regulate membrane curvature, e.g.
the BAR domain of endophilin stabilises membrane cur-
vature via a number of electrostatic interactions [34], and
the GTPase Sar1p promotes membrane curvature by inser-
tion of an amphipathic α-helix into the membrane [35].
Conclusion
The data presented here demonstrate the identification of
a potential PtdOH-binding site by phage display, in the
first intracellular loop of GLUT4. Mutation of this site is
capable of modulating the efficiency of GLUT4-contain-
ing vesicle fusion. It remains to be shown how this motif
regulates fusion, whether by favouring membrane curva-
ture or recognition of the vesicle by other trafficking regu-
lators. This region is unique to GLUT4 among the sugar
4A mutation causes defect in fusion of GLUT4-containing vesicles at the plasma membraneFigure 4
4A mutation causes defect in fusion of GLUT4-containing vesicles at the plasma membrane. 3T3-L1 adipocytes 
transfected with wild type (WT, black bars) or 4A mutant (MUT, grey bars) pGLUT4HA-GFP. Cells were serum-starved for 4 
hr prior to stimulation with 83 nM insulin for 30 min. The ratio of Alexa633 to GFP signals at the plasma membrane was quan-
tified as described in Materials and Methods. Histogram (a) shows distribution of ratios for wild type and mutant GLUT4-
expressing cells expressed as a % of the total in each condition, and is representative of 3 independent experiments. Graph (b) 
shows means of 3 independent experiments ± SEM. The difference between wild type and mutant mean values is statistically 
significant (t-test P < 0.05, ANOVA P < 0.0005).Page 5 of 8
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of regulation involving lipid signalling.
Methods
Materials
Lipids egg phosphatidylcholine (PtdCho), and palmitoyl
oleoyl phosphatidic acid (PtdOH) were from Avanti Polar
Lipids (Alabama, U.S.A). Tetramethylbenzidine (TMB)
super sensitive peroxidase substrate was from Tebu-bio
(Peterborough, U.K). Fatty acid-free bovine serum albu-
min was from Sigma (Gillingham, U.K). Mouse mono-
clonal anti-HA antibody was from Covance (Cambridge
Antibody Technologies, Cambridge, U.K.). Cell culture
medium and Alexa-tagged secondary antibodies were
from Invitrogen (Paisley, U.K).
Screening by phage display
96-well dilution plate wells (Falcon) were coated with
200 pmoles per well egg phosphatidylcholine or palmi-
toyl oleoyl phosphatidic acid in hexane/ethanol 1:1.
Plates were dried in air for 1 hr, then under vacuum for 1
hr. Lipid-coated and uncoated wells were blocked with
blocking buffer (0.1 M NaHCO3, 5 mg/ml BSA, 0.02%
NaN3, 2.5 μM CaCl2 pH8.6) at 4°C overnight, then the
wells washed six times with TBST (50 mM Tris.HCl pH
7.5, 150 mM NaCl, 0.1% Tween20, 2.5 μM CaCl2). An
M13 12-mer phage library (New England Biolabs) diluted
in TBST was panned sequentially over plastic (non-coated
wells), egg PtdCho then PtdOH surfaces. Phage not
bound to the PtdOH surface were washed away with
TBST, and bound phage were eluted with phage elution
buffer (0.5 mM glycerol-3-phosphate, 50 mM Tris.HCl pH
7.5, 150 mM NaCl, 0.1% Tween20, 2.5 μM CaCl2). Pan-
ning was repeated for second and third rounds, after
which PtdOH-specific phage were isolated and amplified
according to the manufacturer's protocol. The phage
DNAs encoding the 12-mer peptides were sequenced and
the resulting sequences entered as BLAST database que-
ries.
Constructs
pCis-GLUT4HA (HA-tag in first exofacial loop) was
obtained from Prof. G. Gould. The GLUT4HA open read-
ing frame was cloned by PCR into pEGFPn2 to produce
pGLUT4HA-GFP, and verified by sequencing. Site-
directed mutagenesis of Ser103-Leu106 to alanines (Strat-
agene, Quikchange kit) was carried out according to the
manufacturer's protocol.
Cell culture and transfection
3T3-L1 fibroblasts were cultured in Dulbecco's Modified
Eagle Medium (DMEM) supplemented with 10% foetal
calf serum and penicillin/streptomycin. Cells were pas-
saged every 3 days to maintain 30–90% confluence. Dif-
ferentiation into adipocytes was carried out as described
previously [36]. 3T3-L1 adipocytes were transfected by
electroporation, 90 μg DNA per 0.4 cm cuvette (180 V,
950 μF) then seeded in coverslip-bottomed dishes.
Confocal microscopy GLUT4 translocation assay
Transfected 3T3-L1 adipocytes on collagen-coated glass
coverslips (Mattek) were serum-starved for 4 hr prior to
stimulation with 83 nM insulin for 30 min at 37°C. All
further steps were carried out at room temperature. After
stimulation, cells were fixed with 4% paraformaldehyde
for 20 min. Coverslips were washed three times with
phosphate buffered saline (PBS), and blocked with 3%
bovine serum albumin (BSA) in PBS for 45 min. Primary
antibody mouse monoclonal anti-HA (Covance) was
incubated at 1:500 in blocking buffer for 45 min. After
washing three times in PBS, secondary antibody Alexa
633-conjugated anti-mouse IgG (Invitrogen) was used at
1:500 in blocking buffer and incubated for 45 min. Slides
were washed three times in PBS and left in PBS in the dark
at 4°C ready for microscope analysis.
GFP-expressing cells were imaged using a Leica DM IRBE
system with 488 nm excitation for GFP and 633 nm exci-
tation for the Alexa 633 secondary antibody. Emission fil-
ters were set at 499–551 nm for GFP and 649–682 for
Alexa 633. PMT settings were kept constant during indi-
vidual assays to allow quantification. At least 35 cells were
imaged from each condition, and the images analysed
using Metamorph software (Molecular Devices). Trans-
fected cells were selected, and the average pixel intensity
for both GFP and 633 channels calculated. These values
were used to calculate a ratio of the proportion of
GLUT4HA-GFP exposed at the plasma membrane relative
to the total level of protein expressed. Further analysis of
the GFP:633 ratio was carried out by selecting the plasma
membrane of the cell as the region of interest; this allows
a determination of the efficiency of GLUT4 insertion
(fusion) into the plasma membrane to be undertaken.
Pixel intensity values were corrected for background of
non-transfected cells, and normalised to the wild type
GLUT4 insulin response data. Insulin-induced transloca-
tion from the intracellular storage compartment to the
plasma membrane region was assessed by the ratio of
plasma membrane GFP: whole cell GFP signals. 13 to 31
cells were analysed for each condition, and the mean
ratios calculated. Statistical analysis used the Student's T
test and ANOVA on SPSS 13.0 software.
Authors' contributions
CAH carried out the molecular biology, microscopy and
image analysis, participated in the sequence alignment
and drafted the manuscript. TRP carried out the phage dis-
play and participated in the sequence alignment. SEL,
GIW and JMT participated in the design and coordination
of microscopy experiments, and helped draft the manu-Page 6 of 8
(page number not for citation purposes)
BMC Cell Biology 2008, 9:25 http://www.biomedcentral.com/1471-2121/9/25script. SEL also participated in carrying out the micro-
scope work. MJOW supervised the design and
coordination of all experiments and helped draft the man-
uscript.
Acknowledgements
This work was supported by funding from the Wellcome Trust (to MJOW) 
and the Medical Research Council (to JMT). CAH was supported by a Well-
come Trust Studentship. pCis-GLUT4HA was generously provided by Prof. 
Gwyn Gould.
References
1. Iyer SS, Barton JA, Bourgoin S, Kusner DJ: Phospholipases D1 and
D2 coordinately regulate macrophage phagocytosis.  J Immu-
nol 2004, 173(4):2615-2623.
2. Pathre P, Shome K, Blumental-Perry A, Bielli A, Haney CJ, Alber S,
Watkins SC, Romero G, Aridor M: Activation of phospholipase
D by the small GTPase Sar1p is required to support COPII
assembly and ER export.  Embo J 2003, 22(16):4059-4069.
3. Powner DJ, Payne RM, Pettitt TR, Giudici ML, Irvine RF, Wakelam MJ:
Phospholipase D2 stimulates integrin-mediated adhesion via
phosphatidylinositol 4-phosphate 5-kinase Igamma b.  J Cell Sci
2005, 118(Pt 13):2975-2986.
4. Baillie GS, Huston E, Scotland G, Hodgkin M, Gall I, Peden AH, Mac-
Kenzie C, Houslay ES, Currie R, Pettitt TR, Walmsley AR, Wakelam
MJ, Warwicker J, Houslay MD: TAPAS-1, a novel microdomain
within the unique N-terminal region of the PDE4A1 cAMP-
specific phosphodiesterase that allows rapid, Ca2+-triggered
membrane association with selectivity for interaction with
phosphatidic acid.  J Biol Chem 2002, 277(31):28298-28309.
5. Ghosh S, Strum JC, Sciorra VA, Daniel L, Bell RM: Raf-1 kinase pos-
sesses distinct binding domains for phosphatidylserine and
phosphatidic acid. Phosphatidic acid regulates the transloca-
tion of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stim-
ulated Madin-Darby canine kidney cells.  J Biol Chem 1996,
271(14):8472-8480.
6. Delon C, Manifava M, Wood E, Thompson D, Krugmann S, Pyne S,
Ktistakis NT: Sphingosine kinase 1 is an intracellular effector
of phosphatidic acid.  J Biol Chem 2004, 279(43):44763-44774.
7. Litosch I: Regulation of phospholipase C-beta(1) activity by
phosphatidic acid.  Biochemistry 2000, 39(26):7736-7743.
8. Limatola C, Barabino B, Nista A, Santoni A: Interleukin 1-beta-
induced protein kinase C-zeta activation is mimicked by
exogenous phospholipase D.  Biochem J 1997, 321 ( Pt
2):497-501.
9. Stahelin RV, Burian A, Bruzik KS, Murray D, Cho W: Membrane
binding mechanisms of the PX domains of NADPH oxidase
p40phox and p47phox.  J Biol Chem 2003, 278(16):14469-14479.
10. Manifava M, Thuring JW, Lim ZY, Packman L, Holmes AB, Ktistakis
NT: Differential binding of traffic-related proteins to phos-
phatidic acid- or phosphatidylinositol (4,5)- bisphosphate-
coupled affinity reagents.  J Biol Chem 2001, 276(12):8987-8994.
11. Rodi DJ, Makowski L: Phage-display technology--finding a nee-
dle in a vast molecular haystack.  Curr Opin Biotechnol 1999,
10(1):87-93.
12. Zucconi A, Dente L, Santonico E, Castagnoli L, Cesareni G: Selec-
tion of ligands by panning of domain libraries displayed on
phage lambda reveals new potential partners of synaptojanin
1.  J Mol Biol 2001, 307(5):1329-1339.
13. Whitley P, Reaves BJ, Hashimoto M, Riley AM, Potter BV, Holman
GD: Identification of mammalian Vps24p as an effector of
phosphatidylinositol 3,5-bisphosphate-dependent endosome
compartmentalization.  J Biol Chem 2003, 278(40):38786-38795.
14. Miura Y, Sasao Y, Kamihira M, Sakaki A, Iijima S, Kobayashi K: Pep-
tides binding to a Gb3 mimic selected from a phage library.
Biochim Biophys Acta 2004, 1673(3):131-138.
15. Kanai F, Ito K, Todaka M, Hayashi H, Kamohara S, Ishii K, Okada T,
Hazeki O, Ui M, Ebina Y: Insulin-stimulated GLUT4 transloca-
tion is relevant to the phosphorylation of IRS-1 and the activ-
ity of PI3-kinase.  Biochem Biophys Res Commun 1993,
195(2):762-768.
16. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M: Essential role
of phosphatidylinositol 3-kinase in insulin-induced glucose
transport and antilipolysis in rat adipocytes. Studies with a
selective inhibitor wortmannin.  J Biol Chem 1994,
269(5):3568-3573.
17. Clarke JF, Young PW, Yonezawa K, Kasuga M, Holman GD: Inhibi-
tion of the translocation of GLUT1 and GLUT4 in 3T3-L1
cells by the phosphatidylinositol 3-kinase inhibitor, wort-
mannin.  Biochem J 1994, 300 ( Pt 3):631-635.
18. Sajan MP, Bandyopadhyay G, Kanoh Y, Standaert ML, Quon MJ, Reed
BC, Dikic I, Farese RV: Sorbitol activates atypical protein kinase
C and GLUT4 glucose transporter translocation/glucose
transport through proline-rich tyrosine kinase-2, the extra-
cellular signal-regulated kinase pathway and phospholipase
D.  Biochem J 2002, 362(Pt 3):665-674.
19. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert M, Farese
RV Jr., Farese RV: Activation of the ERK pathway and atypical
protein kinase C isoforms in exercise- and aminoimidazole-
4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glu-
cose transport.  J Biol Chem 2002, 277(26):23554-23562.
20. Millar CA, Meerloo T, Martin S, Hickson GR, Shimwell NJ, Wakelam
MJ, James DE, Gould GW: Adipsin and the glucose transporter
GLUT4 traffic to the cell surface via independent pathways
in adipocytes.  Traffic 2000, 1(2):141-151.
21. Shome K, Vasudevan C, Romero G: ARF proteins mediate insu-
lin-dependent activation of phospholipase D.  Curr Biol 1997,
7(6):387-396.
22. Standaert ML, Bandyopadhyay G, Zhou X, Galloway L, Farese RV:
Insulin stimulates phospholipase D-dependent phosphatidyl-
choline hydrolysis, Rho translocation, de novo phospholipid
synthesis, and diacylglycerol/protein kinase C signaling in L6
myotubes.  Endocrinology 1996, 137(7):3014-3020.
23. Huang P, Altshuller YM, Hou JC, Pessin JE, Frohman MA: Insulin-
stimulated plasma membrane fusion of Glut4 glucose trans-
porter-containing vesicles is regulated by phospholipase D1.
Mol Biol Cell 2005, 16(6):2614-2623.
24. Seiler AE, Henderson A, Rubin R: Ethanol inhibits insulin recep-
tor tyrosine kinase.  Alcohol Clin Exp Res 2000, 24(12):1869-1872.
25. Powner DJ, Hodgkin MN, Wakelam MJ: Antigen-stimulated acti-
vation of phospholipase D1b by Rac1, ARF6, and PKCalpha
in RBL-2H3 cells.  Mol Biol Cell 2002, 13(4):1252-1262.
26. Emoto M, Klarlund JK, Waters SB, Hu V, Buxton JM, Chawla A, Czech
MP: A role for phospholipase D in GLUT4 glucose trans-
porter translocation.  J Biol Chem 2000, 275(10):7144-7151.
27. Kooijman EE, Chupin V, Fuller NL, Kozlov MM, de Kruijff B, Burger
KN, Rand PR: Spontaneous curvature of phosphatidic acid and
lysophosphatidic acid.  Biochemistry 2005, 44(6):2097-2102.
28. Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Tennenbaum T, Sampson
SR: Activation of protein kinase C zeta induces serine phos-
phorylation of VAMP2 in the GLUT4 compartment and
increases glucose transport in skeletal muscle.  Mol Cell Biol
2001, 21(22):7852-7861.
29. De Camilli P, Emr SD, McPherson PS, Novick P: Phosphoinositides
as regulators in membrane traffic.  Science 1996,
271(5255):1533-1539.
30. Hay JC, Fisette PL, Jenkins GH, Fukami K, Takenawa T, Anderson RA,
Martin TF: ATP-dependent inositide phosphorylation
required for Ca(2+)-activated secretion.  Nature 1995,
374(6518):173-177.
31. Way G, O'Luanaigh N, Cockcroft S: Activation of exocytosis by
cross-linking of the IgE receptor is dependent on ADP-ribo-
sylation factor 1-regulated phospholipase D in RBL-2H3
mast cells: evidence that the mechanism of activation is via
regulation of phosphatidylinositol 4,5-bisphosphate synthe-
sis.  Biochem J 2000, 346 Pt 1:63-70.
32. Kazanietz MG, Caloca MJ, Eroles P, Fujii T, Garcia-Bermejo ML, Reilly
M, Wang H: Pharmacology of the receptors for the phorbol
ester tumor promoters: multiple receptors with different
biochemical properties.  Biochem Pharmacol 2000,
60(10):1417-1424.
33. Hodgkinson CP, Mander A, Sale GJ: Protein kinase-zeta interacts
with munc18c: role in GLUT4 trafficking.  Diabetologia 2005,
48(8):1627-1636.
34. Gallop JL, Jao CC, Kent HM, Butler PJ, Evans PR, Langen R, McMahon
HT: Mechanism of endophilin N-BAR domain-mediated
membrane curvature.  Embo J 2006, 25(12):2898-2910.
35. Lee MC, Orci L, Hamamoto S, Futai E, Ravazzola M, Schekman R:
Sar1p N-terminal helix initiates membrane curvature andPage 7 of 8
(page number not for citation purposes)
BMC Cell Biology 2008, 9:25 http://www.biomedcentral.com/1471-2121/9/25Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
completes the fission of a COPII vesicle.  Cell 2005,
122(4):605-617.
36. Oatey PB, Van Weering DH, Dobson SP, Gould GW, Tavare JM:
GLUT4 vesicle dynamics in living 3T3 L1 adipocytes visual-
ised with green fluorescent protein.  Biochemical Journal 1997,
327:637-642.Page 8 of 8
(page number not for citation purposes)
